Monthly reportRWANDAFDA
Rwanda Food and Drugs Authority — April 2026
What this register recorded from RWANDAFDA in April 2026, what other African authorities published in the same month that bears on it, and what we could not read in RWANDAFDA’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about Rwanda Food and Drugs Authority.
What RWANDAFDA published
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-RW-2026-41816952 | 24 Apr 2026 | RW | Akerol 2.5mg/5ml sp F/60ml WEST COAST PHARMACEUTICAL WORKS Ltd, India | none published | Recall | Class II | Tier 1 · Regulator-published |
What other authorities published
On an event RWANDAFDA has no record of
- Substandard iohexol contrast media — Egyptian Drug Authority (EG), 2026-04-01: Omnipaque 300 mg/ml
- Substandard iohexol contrast media — South African Health Products Regulatory Authority (ZA), 2026-04-20: Contrast media (iohexol)
What we could not read in RWANDAFDA’s notices
- 159 record(s) held from RWANDAFDA in total
- 2 carry no publication date we could read
- 22 name neither a batch nor a stated reason
- 1 name no manufacturer
- 2 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
- 0 have no archived copy of the original notice
Correcting this
Anything on this page that is wrong about Rwanda Food and Drugs Authority can be corrected by Rwanda Food and Drugs Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.